If that were true, that would mean Missling has some sort of pre-arranged deal with Biogen. That would also mean that Missling has agreed to a price that he believes is fair. That number would have to be ridiculously high.
Missling knows our science. He knows how low the bar is for all of the indications we are going for. He knows there is the 21st century cures act and there is the potential for approval for one or more of our indications in the very near future. Knowing all of this information, would lead me to believe that he would laugh at most offers.
The bottom line is, if a company really wants to take us over, they can and will be successful. And it will be for much cheaper than a complete buy out offer. If he really feels like we were threatened, which he probably does, considering what we are sitting on, then he is feeling a real sense of urgency at this point.
So, the only way to protect shareholders, to get valued as close to what we deserve, to attract higher bids, etc. Is to execute Quickly. To increase value. The better and faster we execute, the higher our share price becomes, the harder it will be for a takeover, the more options we will have because of the potentially increased access to raising funds. So, Missling wants to move this just as fast or faster than we do. But it can't be done sloppily.
BPs trying to do a takeover, buyout, etc. also know this. They obviously know, the time to strike is now. Before we don't need them anymore. Before we become too expensive. Or justifiably expensive to their boards.
And the more info, data we put out there. The more bees there will be swarming to our honey. It's a crazy chess game and a delicate balancing act. I'm glad Missling is in charge.
News 
Market Data 
Discover 
AI
